Atopic dermatitis (AD) is a common chronic inflammatory skin condition characterised by pruritus and recurrent eczematous patches plaques. It impacts sleep its visibility can lead to stigmatisation, low self-esteem, social withdrawal, reduced quality of life (QOL), psychological burden. This study explores the relationship between AD mental health, including possible causation pathways. A literature review was conducted in PubMed without using limiters. carries higher odds suicidality an...

A 63-year-old gentleman was referred to the dermatology clinic with a 10-month history of progressive erythema, scaling, swelling and pain his right index finger after minor gardening injury. This began at fingertip, extended proximally led reduced range motion in distal interphalangeal joint, nail dystrophy pustulation. What is most likely diagnosis?

A woman with metastatic melanoma was treated immunotherapy induction ipilimumab and nivolumab radiotherapy to liver metastases. The patient deteriorated shortly thereafter, becoming febrile hypotensive requiring admission the intensie care unit (ICU) for inotrope support. Failure respond antibiotics a negative septic screen prompted further investigation, which ultimately led diagnosis of haemophagocytic lymphohistiocytosis (HLH). improved on high dose steroids discharged home. Months later,...

A Caucasian woman in her late 60s was referred to dermatology with itchy eczematous papules and plaques spreading from the shins chest, back upper arms over 3 months. She had two past non-melanoma skin cancers; otherwise, medical medication histories were unremarkable. An

Alopecia areata (AA) presents a challenging and unpredictable condition associated with substantial psychosocial financial burdens. A chronic, relapsing form of non-scarring hair loss, it affects approximately 0.1–0.2% the population worldwide lifetime risk 1.0% to 2.1%. The implications AA, including its association depression, anxiety, social phobia, employment disruption, relationship challenges are well described. Significant economic costs AA include those healthcare, lost income,...

This case series aims to evaluate the demographic features, disease characteristics, and treatment outcomes of 8 patients receiving subcutaneous (SC) adalimumab for severe, refractory vulval lichen sclerosus (VLS) and/or planus (VLP). Both conditions are chronic inflammatory dermatoses that significantly impair quality life, although first-line typically involves potent ultrapotent topical corticosteroids, managing severe cases is challenging due a lack FDA-approved systemic therapies....

ABSTRACT Aim A retrospective study will review episodes of anaphylaxis during bee venom immunotherapy (BVIT) in children, any modifications made to the dosing schedule, and subsequent outcomes over a nine‐year period Western Australia. Methods Patient demographics, dose eliciting BVIT, BVIT regimen following (i.e., continuation, modification, or cessation), were collected for children commenced on from 1st September 2012 31st August 2021. Results total 624 12/624 (1.9%) did not complete...

A 2-year-old girl, weighing 5 kg, with Wolf-Hirschhorn syndrome (WHS) was admitted to the Perth Children's Hospital in Western Australia following initial onset of multiple seizures and coryza. Her remaining past medical family history unremarkable. She commenced on antiepileptics: levetiracetam admission, then phenobarbitone Day 3 sodium valproate 9 her admission respectively. subsequently diagnosed human metapneumovirus pneumonitis, Haemophilus influenzae pneumonia a methicillin-resistant...

Abstract Red Ear Syndrome is an uncommon disorder that can affect all age groups. It frequently referred to Dermatology as it present similarly erythromelalgia. Although the exact pathophysiology unknown, a common hypothesis suggests shared pathophysiological background with migraine due their well‐known association. Currently, there are no established treatment guidelines. Delays in accurate diagnosis and commencing optimal significantly negatively impact on patients quality of life. We...